United Therapeutics to repurchase remainder under $2.0 billion authorization
United Therapeutics Corporation announced an accelerated share repurchase agreement for the remainder of its $2.0 billion authorization.
Story updates
11:00:31 AM UTC
SquawkNews
United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement For Remainder Of $2.0 Billion Authorization >UTHR
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.